Acute Urticaria: Sudden Hive Outbreaks

Clinical Overview

Acute Urticaria is characterized by abrupt onset of wheals and/or angioedema lasting <6 weeks (typically 4-6 weeks), usually self-limited and resolving without treatment. In contrast to chronic urticaria (>6 weeks duration), acute urticaria often has identifiable triggers—most commonly infections (viral URI, streptococcal pharyngitis) and medications (antibiotics, NSAIDs)—though up to 50% of cases have no identified cause. Acute urticaria is common in primary care and pediatric practice, affecting 15-20% of population at some point. While usually benign, acute urticaria can rarely progress to anaphylaxis, requiring patient education on warning signs.

Epidemiology & Risk Factors

Acute urticaria affects children and adults across all ages, with peak incidence in young adults. Viral infections are responsible for 30-50% of acute urticaria cases: URI viruses (rhinovirus, coronavirus), EBV, CMV, and hepatitis B. Bacterial infections, particularly Group A Streptococcal pharyngitis, account for 15-25% of cases. Medications cause 10-15%: antibiotics (especially penicillins, TMP-SMX), NSAIDs, and ACE inhibitors are common. Food allergy (IgE-mediated) causes 5-10%, particularly in children: shellfish, tree nuts, peanuts, eggs, and milk are leading culprits. Insect bites/stings cause 5-8%. Approximately 40-50% of cases are idiopathic. Upper socioeconomic status, atopic history, and female gender are mild risk factors. Recent vaccination (particularly for hepatitis B, yellow fever) rarely triggers acute urticaria in 1-3% of vaccinees.

Pathophysiology

Acute urticaria results from mast cell and basophil degranulation releasing mediators: histamine (causes wheals within minutes), tryptase, leukotrienes, prostaglandins, and cytokines. IgE-mediated reactions (food allergy, insect venom, certain drugs) cause mast cell activation via cross-linking of FceRI. Immune complex-mediated reactions (post-infectious, serum sickness) activate complement, generating C3a and C5a anaphylatoxins that activate mast cells. Viral infections may cause direct mast cell activation or molecular mimicry triggering autoimmune responses. Non-immunologic mechanisms (NSAID-induced via COX inhibition, pseudoallergens in foods affecting arachidonic acid metabolism) also contribute. The acute inflammatory response typically peaks within 24-72 hours, then subsides as mast cell mediator stores become depleted and are not rapidly replenished.

Clinical Presentation & Classification

Acute urticaria presents with sudden onset of pruritic wheals: erythematous, edematous papules or plaques that blanch with pressure, lasting <24 hours at individual sites. Central clearing ("target" lesions) may occur. Angioedema (swelling of dermis and subcutaneous tissue) involves lips, tongue, eyelids, face, or hands in 40-50% of cases. Systemic symptoms are typically absent unless progressing to anaphylaxis (airway swelling, hypotension, syncope, GI symptoms). Lesions may continue appearing over several hours to days, with new lesions developing while older ones resolve, creating impression of persistent rash.

Classification by extent:

• Localized: lesions in one body region
• Generalized: widespread distribution

Severity factors: Angioedema, particularly facial/airway involvement; numerous lesions (>50); systemic symptoms; or rapid progression warrant consideration of anaphylaxis risk.

Diagnosis & Workup

Diagnosis is clinical based on characteristic wheals lasting <24 hours per site and symptoms lasting <6 weeks total. Laboratory testing is typically unrevealing and not recommended by AAD guidelines unless specific triggers are suspected.

Testing should focus on likely triggers:

• Infection screening: Throat culture or rapid strep test if pharyngitis suspected; CBC/differential if atypical lymphocytosis suggests viral infection; consider EBV serology in patients with fever, lymphadenopathy, pharyngitis
• Food allergy evaluation: Skin prick testing or serum-specific IgE (ImmunoCAP) only if food allergy strongly suspected (e.g., urticaria within 1 hour of eating shellfish, known atopic disease); comprehensive food panels are not cost-effective
• Drug causality: Careful medication history—NSAIDs and antibiotics initiated within 1 week before urticaria onset should be discontinued
• Autologous serum skin test (ASST): Not recommended in acute urticaria; more relevant for chronic urticaria
• Skin biopsy: Only if atypical features suggest urticarial vasculitis (histology shows leukocytoclastic vasculitis)

ESR elevation suggests vasculitis rather than simple urticaria.

Treatment Algorithm

First-line: Second-generation H1 antihistamines. Cetirizine 10 mg once daily, loratadine 10 mg once daily, or fexofenadine 180 mg once daily. Continuous dosing superior to PRN dosing. Onset: 1-2 hours. Continue for 3-5 days minimum; many cases improve over 1-2 weeks with antihistamines alone. First-generation antihistamines (diphenhydramine 25-50 mg) are sedating but may be preferred in children where non-sedating options are less effective. Duration: Continue through symptom resolution, then taper over 3-5 days to prevent rebound.

Refractory cases or moderate-to-severe disease: Add short-course systemic corticosteroids. Prednisone 0.5-1 mg/kg/day (typically 20-40 mg) for 3-5 days (no taper needed for such short courses). Efficacy: accelerates resolution of lesions by 1-3 days. Use reserved for cases with moderate-to-severe symptoms or extensive lesions; not needed for mild cases, as antihistamines alone typically suffice.

Anaphylaxis risk/severe angioedema: IM epinephrine 0.3-0.5 mg (1:1000) immediately if signs of anaphylaxis (airway edema, hypotension, chest symptoms). Have epinephrine auto-injectors (EpiPen) available for patients with food allergy-induced urticaria.

Trigger identification and avoidance: If infection identified (strep throat), treat with appropriate antibiotics (penicillin V 250 mg QID or amoxicillin 500 mg TID for 10 days). If food allergy identified, strict avoidance. If medication-induced, discontinue and note for future reference.

Prognosis & Complications

Prognosis is excellent: 95% of cases resolve completely within 4-6 weeks without long-term sequelae. Recurrence of acute urticaria episodes is common (50% have ≥1 additional episode), but each episode is typically self-limited. Anaphylaxis is rare, occurring in <0.01% of acute urticaria cases, though risk is higher in IgE-mediated food/venom reactions. Progression to chronic urticaria (>6 weeks) occurs in 5-10% of acute cases.

When to See a Dermatologist

Seek evaluation if urticaria persists >2 weeks, worsens despite antihistamines, or if you develop angioedema involving the face or airway. Call 911 or go to emergency department if you have difficulty breathing, throat swelling, or signs of anaphylaxis.

Frequently Asked Questions

Is acute urticaria an allergic reaction?

Sometimes, but not always. Acute urticaria can be IgE-mediated (true allergic reaction from food, insect venom) or non-allergic (infection-triggered, medication-induced, or idiopathic). Your doctor can evaluate for specific triggers, but in 40-50% of cases, the cause is never identified despite thorough investigation.

Should I get allergy testing to identify the trigger?

Not routinely. Extensive allergy testing is low-yield in acute urticaria since 40-50% have no identifiable cause and triggers are often viral infections (not testable). Testing is appropriate only if specific triggers are suspected (e.g., shellfish allergy if urticaria occurs after eating shellfish; bee sting if urticaria follows bee encounter). Random panels are wasteful and often false-positive.

Will acute urticaria become chronic?

Unlikely—only 5-10% of acute urticaria cases progress to chronic urticaria (>6 weeks duration). Most resolve completely within 4-6 weeks. However, if your urticaria persists beyond 6 weeks, it's then classified as chronic urticaria and may require different management (escalation to omalizumab, etc.).

What should I do if I think I'm having an allergic reaction?

If you have difficulty breathing, throat swelling, dizziness, or chest pain, call 911 immediately—these signs suggest anaphylaxis. If you have only wheals and itching without systemic symptoms, take an antihistamine (cetirizine, loratadine) and monitor. Seek urgent medical attention if symptoms worsen or systemic signs develop.

References